# Vasa Previa and the Role of Fetal Fibronectin and Cervical Length Surveillance: A Review

## TL;DR

This review discusses vasa previa, a dangerous pregnancy condition, and how fetal fibronectin and cervical length monitoring may help predict preterm labor.

## Contribution

The paper reviews existing literature to explore the potential role of FFN and CL surveillance in managing vasa previa.

## Key findings

- Fetal fibronectin and cervical length surveillance can predict preterm labor in pregnancies.
- There is limited direct evidence on FFN and CL's impact on vasa previa management.
- These tools may help identify pregnancies at risk for preterm labor, improving outcomes.

## Abstract

Vasa previa is a pregnancy complication that occurs when unprotected fetal blood vessels traverse the cervical os, placing the fetus at high risk of exsanguination and fetal death. These fetal vessels may be compromised by fetal movement and compression, leading to poor oxygen distribution and asphyxiation. Diagnostic tools for vasa previa management and preterm labor (PTL) include transvaginal ultrasound, cervical length (CL) surveillance and use of fetal fibronectin (FFN) testing. These tools can prove to be quite useful as they allow for lead time in the prediction of PTL and spontaneous rupture of membranes which can result in devastating outcomes for pregnancies affected by vasa previa. We conducted a literature review on vasa previa management and the usefulness of FFN and CL surveillance in predicting PTL and found 36 related papers. Although there is limited research available to show the impact of FFN and CL surveillance in the management of vasa previa, there is sufficient evidence to support FFN and CL surveillance in predicting the onset of PTL, which can have devastating consequences for the pregnancies affected. It can be extrapolated that these tools, by helping to determine pregnancies at risk for PTL, could improve management and outcomes in patients with vasa previa. Future studies investigating the management of vasa previa with FFN and CL surveillance to reduce the burden of PTL and its associated comorbidities are warranted.